Xiaolong Fan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaolong Fan has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Stefan Karlsson
Department of Molecular Medicine and Gene Therapy, Lund University, SE‐22184 Lund, Sweden
2 shared publicationsAndré Lieber
Division of Medical Genetics, Department of Medicine, University of Washington, Seattle, Washington 98195, USA
1 shared publicationAnn Brun
Department of Molecular Medicine and Gene Therapy, and Stem Cell Laboratory, Department of Laboratory Medicine, Lund University, 223 62 Lund, Sweden
1 shared publicationBengt Widegren
Department of Immunology, Lund University, SE‐22184 Lund, Sweden
1 shared publicationJohan Ljungberg
Department of Molecular Medicine and Gene Therapy, Lund University, SE‐22184 Lund, Sweden
1 shared publicationJohan Richter
Department of Molecular Medicine and Gene Therapy, Lund University, SE‐22184 Lund, Sweden
1 shared publication
Latest Publications
- 10 March 2004
- Published by Wiley in The Journal of Gene Medicine
- Vol. 6 (6) , 631-641
Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells
Background: A paucity of coxsackie adenovirus receptor (CAR) hampers the adenovirus serotype 5 (Ad5)‐based vector‐mediated gene transfer into malignant hematopoietic cells. Fiber‐retargeted adenoviral vectors with species B tropism can potentially bypass the CAR requirement and facilitate efficient gene transfer into malignant hematopoietic cells.Methods: For feasible generation of fiber‐retargeted adenoviral vectors, we have modified the versatile AdEasy system with a chimeric fiber gene encoding the Ad5 fiber tail domain and Ad35 fiber shaft and knob domains. An Ad5‐based vector encoding the green fluorescent protein (GFP) gene under the control of the PGK promoter with Ad35 fiber receptor specificity was generated (Ad5F35‐GFP). The Ad5F35‐GFP vector‐mediated gene transfer efficiency was compared with a fiber non‐modified Ad5‐GFP vector, which also encodes the GFP gene under the control of the PGK promoter.Results: We demonstrated that a variety of Ad5‐refractory malignant myeloid and B lymphoid cell lines were highly permissive to the Ad5F35‐GFP vector infection. Importantly, primary chronic myeloid leukemic (CML) cells and chronic lymphocytic leukemia (CLL) B cells were superiorly transduced by the Ad5F35‐GFP vector at a multiplicity of infection (MOI) of 100 compared with the Ad5‐GFP vector.Conclusions: Our study will facilitate the generation of fiber‐retargeted adenoviral vectors and enable transient genetic manipulation of primary malignant hematopoietic cells. Copyright © 2004 John Wiley & Sons, Ltd.
- 10 March 2004
- Published by Wiley in The Journal of Gene Medicine
- Vol. 6 (6) , 631-641
Development of an adenoviral vector system with adenovirus serotype 35 tropism; efficient transient gene transfer into primary malignant hematopoietic cells
Background: A paucity of coxsackie adenovirus receptor (CAR) hampers the adenovirus serotype 5 (Ad5)‐based vector‐mediated gene transfer into malignant hematopoietic cells. Fiber‐retargeted adenoviral vectors with species B tropism can potentially bypass the CAR requirement and facilitate efficient gene transfer into malignant hematopoietic cells.Methods: For feasible generation of fiber‐retargeted adenoviral vectors, we have modified the versatile AdEasy system with a chimeric fiber gene encoding the Ad5 fiber tail domain and Ad35 fiber shaft and knob domains. An Ad5‐based vector encoding the green fluorescent protein (GFP) gene under the control of the PGK promoter with Ad35 fiber receptor specificity was generated (Ad5F35‐GFP). The Ad5F35‐GFP vector‐mediated gene transfer efficiency was compared with a fiber non‐modified Ad5‐GFP vector, which also encodes the GFP gene under the control of the PGK promoter.Results: We demonstrated that a variety of Ad5‐refractory malignant myeloid and B lymphoid cell lines were highly permissive to the Ad5F35‐GFP vector infection. Importantly, primary chronic myeloid leukemic (CML) cells and chronic lymphocytic leukemia (CLL) B cells were superiorly transduced by the Ad5F35‐GFP vector at a multiplicity of infection (MOI) of 100 compared with the Ad5‐GFP vector.Conclusions: Our study will facilitate the generation of fiber‐retargeted adenoviral vectors and enable transient genetic manipulation of primary malignant hematopoietic cells. Copyright © 2004 John Wiley & Sons, Ltd.
- 10 June 2000
- Published by SAGE Publications in Human Gene Therapy
- Vol. 11 (9) , 1313-1327
Efficient Adenoviral Vector Transduction of Human Hematopoietic SCID-Repopulating and Long-Term Culture-Initiating Cells
This article presents our studies on the adenoviral transduction efficiency, level of transgene expression, cell cycle status, and multilineage reconstitution ability of human CD34+ hematopoietic cells transduced under proliferating and survival growth conditions. Bone marrow and umbilical cord blood CD34+ cells were cultured in serum-free medium under survival conditions with thrombopoietin (Tpo) alone, or under proliferating conditions with Tpo, c-Kit ligand (KL), and Flt3 ligand (FL). Adenoviral vectors carrying the enhanced green fluorescent protein (EGFP) gene under the control of the PGK-1 promoter were used to transduce CD34+ cells. Approximately 10% of CD34+ cells were EGFP+ under both culture conditions. In contrast, up to 50% of CD34+CD38- cells were EGFP+, whereas a maximum of 8% of CD34+ CD38high cells were EGFP+ (p < 0.001). Both colony-forming unit cells (CFU-C) and 5-week long-term culture-initiating cells (LTC-ICs) were efficiently transduced. Under survival conditions, a substantial fraction of transduced CD34+ cells remained quiescent. The nondividing CD34+EGFP+ cells contained LTC-ICs capable of reconstituting long-term culture for as long as 10 weeks. CD34+EGFP+ cells also retained the ability to engraft and multilineage-reconstitute NOD/SCID mice. These observations demonstrate that primitive human hematopoietic progenitor cells can be efficiently transduced by adenoviral vectors.
- 10 June 2000
- Published by SAGE Publications in Human Gene Therapy
- Vol. 11 (9) , 1313-1327
Efficient Adenoviral Vector Transduction of Human Hematopoietic SCID-Repopulating and Long-Term Culture-Initiating Cells
This article presents our studies on the adenoviral transduction efficiency, level of transgene expression, cell cycle status, and multilineage reconstitution ability of human CD34+ hematopoietic cells transduced under proliferating and survival growth conditions. Bone marrow and umbilical cord blood CD34+ cells were cultured in serum-free medium under survival conditions with thrombopoietin (Tpo) alone, or under proliferating conditions with Tpo, c-Kit ligand (KL), and Flt3 ligand (FL). Adenoviral vectors carrying the enhanced green fluorescent protein (EGFP) gene under the control of the PGK-1 promoter were used to transduce CD34+ cells. Approximately 10% of CD34+ cells were EGFP+ under both culture conditions. In contrast, up to 50% of CD34+CD38- cells were EGFP+, whereas a maximum of 8% of CD34+ CD38high cells were EGFP+ (p < 0.001). Both colony-forming unit cells (CFU-C) and 5-week long-term culture-initiating cells (LTC-ICs) were efficiently transduced. Under survival conditions, a substantial fraction of transduced CD34+ cells remained quiescent. The nondividing CD34+EGFP+ cells contained LTC-ICs capable of reconstituting long-term culture for as long as 10 weeks. CD34+EGFP+ cells also retained the ability to engraft and multilineage-reconstitute NOD/SCID mice. These observations demonstrate that primitive human hematopoietic progenitor cells can be efficiently transduced by adenoviral vectors.